Home / Health / Weight-Loss Drugs Linked to Micronutrient Deficiencies
Weight-Loss Drugs Linked to Micronutrient Deficiencies
21 May
Summary
- GLP-1 medications may cause micronutrient loss in patients.
- Vitamin supplement sales saw a significant increase in April.
- Studies show deficiencies in Vitamin D, B12, and iron.
A notable increase in multivitamin supplement sales has been observed following the market entry of generic semaglutide, a GLP-1 receptor agonist used for weight loss and diabetes. This surge is attributed to concerns about potential micronutrient deficiencies in patients taking these medications. Sales of vitamin supplements reportedly rose by 11.6% in April compared to the previous month.
Clinicians explain that the appetite suppression associated with GLP-1 medications can lead to reduced food intake, potentially causing muscle loss and other nutritional deficits. Consequently, doctors are recommending vitamin supplements to compensate for these losses and ensure patients maintain adequate nutrient levels.
Research indicates that vitamin D deficiency is a common issue among patients on GLP-1 medications, affecting over 13% in one study. Other deficiencies identified include anemia, iron, and vitamin B. While data specific to India is still developing, experts advise thorough patient screening before prescribing supplements, advocating for a combined approach with nutritionists.
